A pilot recruitment strategy to enhance ethical and equitable access to Covid-19 pediatric vaccine trials
- 23 December 2023
- journal article
- research article
- Published by SAGE Publications in Clinical Trials
- Vol. 21 (3) , 390-396
Abstract
Background/Aims: The SARS-CoV-2 pandemic disproportionately impacted communities with lower access to health care in the United States, particularly before vaccines were widely available. These same communities are often underrepresented in clinical trials. Efforts to ensure equitable enrollment of participants in trials related to treatment and prevention of Covid-19 can raise concerns about exploitation if communities with lower access to health care are targeted for recruitment. Methods: To enhance equity while avoiding exploitation, our site developed and implemented a three-part recruitment strategy for pediatric Covid-19 vaccine studies. First, we publicized a registry for potentially interested participants. Next, we applied public health community and social vulnerability indices to categorize the residence of families who had signed up for the registry into three levels to reflect the relative impact of the pandemic on their community: high, medium, and low. Finally, we preferentially offered study participation to interested families living in areas categorized by these indices as having high impact of the Covid-19 pandemic on their community. Results: This approach allowed us to meet goals for study recruitment based on public health metrics related to disease burden, which contributed to a racially diverse study population that mirrored the surrounding community demographics. While this three-part recruitment strategy improved representation of minoritized groups from areas heavily impacted by the Covid-19 pandemic, important limitations were identified that would benefit from further study. Conclusion: Future use of this approach to enhance equitable access to research while avoiding exploitation should test different methods to build trust and communicate with underserved communities more effectively.Keywords
Funding Information
- Northwestern University Clinical and Translational Sciences Institute
- Clinical and Translational Science Award
- National Institutes of Health (UL1TR001422)
This publication has 13 references indexed in Scilit:
- Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of AgeNew England Journal of Medicine, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?JAMA, 2020
- The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United StatesClinical Infectious Diseases, 2020
- Four Faces of Fair Subject SelectionThe American Journal of Bioethics, 2020
- Burden or Opportunity? Parent Experiences When Approached for Research in a Pediatric Intensive Care UnitEthics & Human Research, 2019
- Racial and Ethnic Disparities in Parental Refusal of Consent in a Large, Multisite Pediatric Critical Care Clinical TrialThe Journal of Pediatrics, 2017
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Are Minority Children Under- or Overrepresented in Pediatric Research?Pediatrics, 2003